Literature DB >> 7504054

Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.

E Vivier1, J M Sorrell, M Ackerly, M J Robertson, R A Rasmussen, H Levine, P Anderson.   

Abstract

Natural killer (NK) cells are CD3:TCR-, CD16+, CD56+ large granular lymphocytes capable of recognizing and eliminating a variety of virus-infected, malignant, and antibody-coated target cells. Two functionally distinct populations of peripheral blood NK cells can be differentiated by their surface expression of an isoform of the neural cell adhesion molecule (CD56). CD56bright NK cells have the attributes of an undifferentiated cell, in that they proliferate in response to exogenous cytokines, but exert poor cytolytic activity. CD56dim NK cells have the attributes of a more differentiated cell, in that they proliferate poorly in response to exogenous cytokines, but are potent cytolytic effector cells. Here we describe the molecular characterization of a NK cell restricted epitope (PEN5) that is selectively expressed on the functionally differentiated CD56dim NK cells. PEN5+ NK cells proliferate poorly in response to interleukin 2 (IL-2), but are potent cytolytic effectors, whereas PEN5- NK cells proliferate in response to IL-2, but are poor cytolytic effectors. Biochemical and immunochemical analyses reveal the PEN5 epitope to be an unusual sulfated poly-N-lactosamine carbohydrate related to keratan sulfate glycosaminoglycans. Immunoprecipitates prepared using a monoclonal antibody reactive with PEN5 include two polydisperse membrane-bound glycoproteins, PEN5 alpha (120-170 kD) and PEN5 beta (210-245 kD). Enzymatic deglycosylation reduces the apparent molecular weight of both PEN5 isoforms by 80-90%, and classifies PEN5 beta as a mucinlike glycoprotein. The surface expression of the PEN5 epitope is downmodulated by stimuli that induce NK cell proliferation, and it is absent from leukemic NK cells of patients with granular lymphocyte proliferative disorder. Taken together, these results indicate that PEN5 is a developmentally regulated poly-N-lactosamine epitope associated with a mucin-type glycoprotein, whose expression is restricted to the population of nonproliferative NK cells fully committed to cytolytic effector function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504054      PMCID: PMC2191265          DOI: 10.1084/jem.178.6.2023

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

Review 1.  Proteoglycans as modulators of growth factor activities.

Authors:  E Ruoslahti; Y Yamaguchi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

2.  Expression and tyrosine phosphorylation of the T cell receptor zeta-subunit in human thymocytes.

Authors:  E Vivier; P Morin; Q S Tian; J Daley; M L Blue; S F Schlossman; P Anderson
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

Review 3.  Physical and biological properties of keratan sulphate proteoglycan.

Authors:  J L Funderburgh; M L Funderburgh; M M Mann; G W Conrad
Journal:  Biochem Soc Trans       Date:  1991-11       Impact factor: 5.407

Review 4.  Mucin-type glycoproteins.

Authors:  G J Strous; J Dekker
Journal:  Crit Rev Biochem Mol Biol       Date:  1992       Impact factor: 8.250

5.  Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.

Authors:  C Leprince; S Cohen-Kaminsky; S Berrih-Aknin; B Vernet-Der Garabedian; D Treton; P Galanaud; Y Richard
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

6.  Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110.

Authors:  A S Freedman; J M Munro; G E Rice; M P Bevilacqua; C Morimoto; B W McIntyre; K Rhynhart; J S Pober; L M Nadler
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

7.  Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing.

Authors:  E Vivier; P Morin; C O'Brien; B Druker; S F Schlossman; P Anderson
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

8.  Mucin-like glycoprotein secreted by cultured hamster tracheal epithelial cells. Biochemical and immunological characterization.

Authors:  R Wu; C G Plopper; P W Cheng
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

9.  Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes.

Authors:  E Vivier; N Rochet; J P Kochan; D H Presky; S F Schlossman; P Anderson
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

10.  Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.

Authors:  M J Robertson; R J Soiffer; S F Wolf; T J Manley; C Donahue; D Young; S H Herrmann; J Ritz
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  14 in total

1.  Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells.

Authors:  E Vivier; M Munroe; P Ariniello; P Anderson
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

2.  The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death.

Authors:  J L Taupin; Q Tian; N Kedersha; M Robertson; P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

3.  Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I.

Authors:  D S Kaufman; R A Schoon; M J Robertson; P J Leibson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

4.  The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas.

Authors:  D Figarella-Branger; L Daniel; P André; S Guia; W Renaud; G Monti; E Vivier; G Rougon
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

5.  FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia.

Authors:  Daniel M Schreeder; Jicun Pan; Fu Jun Li; Eric Vivier; Randall S Davis
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

6.  Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition.

Authors:  Q G Medley; N Kedersha; S O'Brien; Q Tian; S F Schlossman; M Streuli; P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus.

Authors:  Pascal Trempat; Julie Tabiasco; Pascale Andre; Nathalie Faumont; Fabienne Meggetto; Georges Delsol; Randy D Gascoyne; Jean-Jacques Fournie; Eric Vivier; Pierre Brousset
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice.

Authors:  J D Guida; G Fejer; L A Pirofski; C F Brosnan; M S Horwitz
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin.

Authors:  P André; O Spertini; S Guia; P Rihet; F Dignat-George; H Brailly; J Sampol; P J Anderson; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Infection of semen-producing organs by SIV during the acute and chronic stages of the disease.

Authors:  Anna Le Tortorec; Roger Le Grand; Hélène Denis; Anne-Pascale Satie; Karim Mannioui; Pierre Roques; Anne Maillard; Sylvanne Daniels; Bernard Jégou; Nathalie Dejucq-Rainsford
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.